Acknowledgements
The authors would like to acknowledge Bridget Newsom for facilitating
our constant communications with Novartis and her dedicated efforts in
helping obtain tisagenlecleucel on compassionate use protocol for our
patient. We would also like to acknowledge all the members of the
Novartis team who supported our medical team through the pre- and
post-collection challenges.